| Issue Date | Title | Author(s) |
| 2019-12-01 | Low agreement between mMRC rated by patients and clinicians: Implications for practice | Ekström, M; Chang, S; Johnson, MJ; Fazekas, B; Kochovska, S; Huang, C; Currow, DC |
| 2020-03-01 | Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial | Ferreira, DH; Louw, S; McCloud, P; Fazekas, B; McDonald, CF; Agar, MR; Clark, K; McCaffrey, N; Ekström, M; Currow, DC |
| 2019-01-01 | Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain | McCaffrey, N; Flint, T; Kaambwa, B; Fazekas, B; Rowett, D; Currow, DC; Hardy, J; Agar, MR; Quinn, S; Eckermann, S |
| 2019-04-01 | Oral dexamethasone in the management of cancer-related pain: A feasibility study | Eastman, P; Currow, DC; Fazekas, B; Brown, L; Le, B |
| 2019-11-01 | A Randomized, Double-Blind, Multisite, Pilot, Placebo-Controlled Trial of Regular, Low-Dose Morphine on Outcomes of Pulmonary Rehabilitation in COPD | Kochovska, S; Fazekas, B; Hensley, M; Wheatley, J; Allcroft, P; Currow, DC |
| 2020-10 | Evaluation of the IMPACCT Rapid Program: A Cross-Sectional Survey of International Site Investigators. | Hunt, J; Brown, L; Fazekas, B; Doogue, M; Rowett, D; Luckett, T; Morgan, D; Reed-Cox, K; Sheehan, C; Tuffin, P; Currow, DC |
| 2022-01-01 | Opioid-sparing effects of ketorolac in palliative care patients receiving opioids for chronic cancer-related pain: A systematic literature review. | Butcher, B; Hutchings, E; Fazekas, B; Clark, K; Rowett, D; Currow, D |
| 2023-06-01 | Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain. | Matsuoka, H; Clark, K; Fazekas, B; Oyamada, S; Brown, L; Ishiki, H; Matsuda, Y; Hasuo, H; Ariyoshi, K; Lee, J; Le, BH; Fujiwara, N; Miyaji, T; Agar, MR; Yamaguchi, T; Satomi, E; Iwase, S; Phillips, J; Koyama, A; Currow, DC |
| 2020-05 | A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids. | Currow, DC; Clark, K; Louw, S; Fazekas, B; Greene, A; Sanderson, CR |
| 2023-03 | Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness: An Exploratory Study. | Ferreira, DH; Ekström, M; Fazekas, B; Currow, DC |
